Research and Markets: MedImmune Inc - Product Pipeline Report

Business Wire, Jan 4, 2008

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c78543) has announced the addition of MedImmune Inc - Product Pipeline Report to their offering.

The MedImmune Inc Latest Product Pipeline Report contains contact information, business summary, company details, selected financial data, detailed product pipeline (including disease hub, description, therapeutic indication, mechanism of action, drug class, current trial information, trial details and partnering detail), product revenue, trademarks, corporate partners and management profiles.

Our products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes. They are based on the most comprehensive database of private and public biomedical companies available.

Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. We distil and systematize pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide the most comprehensive and up-to-date information available. The MedImmune Inc Product Pipeline Report therefore delivers the latest and the most comprehensive intelligence available on MedImmune Incs current pipeline portfolio.

Content Outline:

Product Pipeline Reports

Business Summary

Contact Information

Selected Financial Data

Company Details

Product Glance (Table/Graph)

Disease Hub Classification (Table/Graph)

Product Pipeline

Product Catalog

Product Details with Description, Therapeutic Indication, Drug Class, Mechanism of Action, Current Trial, Trial Details, Partnering Details etc.

Patent Details (if any)

Recent Financings

Trademarks

Deals & Alliances

Management Profile

Recent Updates

For more information visit http://www.researchandmarkets.com/reports/c78543.>

COPYRIGHT 2008 Business Wire

COPYRIGHT 2008 Gale, Cengage Learning